We therefore speculated SH3BGRL expression would be correlated to survival, however, in contrast to what we predicted, a better survival of patients with high SH3BGRL expression in all cancers was seen (Supplementary Fig. 3C), which was independent of p53 mutation status (Supplementary Fig. 3D). This evidence concerns the gene SH3BGRL and cancer.